Moreover, the findings of the currently available clinical studies have demonstrated that LCDs and intermittent fasting in obese patients (containing those with simultaneous insulin independent diabetes) may result in body fatty mass decline and improvements in metabolic parameters. The gene discussed is INS; the disease is diabetes mellitus.